Bioventus (BVS) Long-Term Investments (2020 - 2026)

Bioventus has reported Long-Term Investments for 7 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 19.7% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 19.7% YoY), and the FY2025 full-year result was $2.3 million, up 21.19% from the prior year.
• Long-Term Investments for Q1 2026 stood at $2.1 million, down from $2.3 million in the prior quarter.
• The five-year high for Long-Term Investments was $78.5 million in Q3 2022, with the low at $1.7 million in Q2 2025.
• Historically, Long-Term Investments has averaged $9.5 million across 5 years, with a median of $2.6 million in 2023.
• Annual changes were most pronounced in 2022 — Long-Term Investments jumped 302.84% — and 2023, when it plunged 91.67%.
• Bioventus' Long-Term Investments stood at $2.6 million in 2022, then increased by 19.84% to $3.1 million in 2023, then plunged by 39.76% to $1.9 million in 2024, then climbed by 21.19% to $2.3 million in 2025, then slipped by 8.33% to $2.1 million in 2026.
• The last three Long-Term Investments figures came in at $2.1 million (Q1 2026), $2.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.